APLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $31,253,525.05

Apellis Pharmaceuticals Insider Trading History Chart

Apellis Pharmaceuticals Share Price & Price History

^$29.28

▼ -0.51 (-1.71%)

As of 01/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Apellis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/22/2025	Cedric Francois	CEO	Sell	13,551	$30.43	$412,356.93	418,519
1/22/2025	David O. Watson	General Counsel	Sell	3,323	$30.43	$101,118.89	144,994
1/22/2025	James George Chopas	CAO	Sell	1,096	$30.43	$33,351.28	48,138
1/22/2025	Nur Nicholson	Insider	Sell	3,948	$30.43	$120,137.64	84,489
1/22/2025	Timothy Eugene Sullivan	CFO	Sell	3,088	$30.43	$93,967.84	129,211
1/17/2025	Cedric Francois	CEO	Sell	6,007	$29.96	$179,969.72	301,408
1/17/2025	David O. Watson	General Counsel	Sell	2,201	$29.96	$65,941.96	105,555
1/17/2025	James George Chopas	CAO	Sell	715	$29.96	$21,421.40	36,643
1/17/2025	Nur Nicholson	Insider	Sell	2,145	$29.96	$64,264.20	52,011
1/17/2025	Timothy Eugene Sullivan	CFO	Sell	1,730	$29.96	$51,830.80	86,370
1/13/2025	Cedric Francois	CEO	Sell	6,247	$28.70	$179,288.90	307,415
1/13/2025	David O. Watson	General Counsel	Sell	4,965	$28.70	$142,495.50	107,756
1/13/2025	James George Chopas	CAO	Sell	783	$28.70	$22,472.10	37,358
1/13/2025	Jeffrey Eisele	Insider	Sell	264	$28.70	$7,576.80	56,881
1/13/2025	Timothy Eugene Sullivan	CFO	Sell	2,170	$28.70	$62,279.00	88,100
1/6/2025	Caroline Baumal	Insider	Sell	2,816	$33.81	$95,208.96	55,560
12/23/2024	Jeffrey Eisele	Insider	Sell	63	$33.09	$2,084.67	57,145
9/16/2024	A. Sinclair Dunlop	Director	Sell	37,000	$36.23	$1,340,510.00	100,000
6/21/2024	A. Sinclair Dunlop	Director	Sell	37,000	$39.24	$1,451,880.00	136,998
5/8/2024	Pascal Deschatelets	Insider	Sell	78,907	$42.35	$3,341,711.45	1,115,983
4/8/2024	Pascal Deschatelets	Insider	Sell	69,107	$54.17	$3,743,526.19	1,115,983
4/1/2024	Timothy Eugene Sullivan	CFO	Sell	4,000	$58.66	$234,640.00	93,338
3/19/2024	A. Sinclair Dunlop	Director	Sell	18,681	$57.18	$1,068,179.58	173,998
3/18/2024	Mark Jeffrey DeLong	Insider	Sell	9,913	$56.90	$564,049.70	54,693
3/15/2024	James George Chopas	CAO	Sell	184	$56.46	$10,388.64	38,883
3/13/2024	Nur Nicholson	Insider	Sell	11,220	$57.56	$645,823.20	56,287
3/1/2024	Cedric Francois	CEO	Sell	250,000	$64.11	$16,027,500.00	313,662
3/1/2024	Timothy Eugene Sullivan	CFO	Sell	6,000	$63.22	$379,320.00	93,338
2/12/2024	Adam J. Townsend	Insider	Sell	1,148	$67.77	$77,799.96	92,453
2/12/2024	Cedric Francois	CEO	Sell	3,962	$67.77	$268,504.74	313,662
2/12/2024	David O. Watson	General Counsel	Sell	781	$67.77	$52,928.37	103,390
2/12/2024	Timothy Eugene Sullivan	CFO	Sell	1,431	$67.77	$96,978.87	93,338
1/29/2024	Cedric Francois	CEO	Sell	2,843	$64.14	$182,350.02	317,624
1/29/2024	David O. Watson	General Counsel	Sell	906	$64.14	$58,110.84	104,171
1/29/2024	Nur Nicholson	Insider	Sell	835	$64.14	$53,556.90	67,507
1/22/2024	Adam J. Townsend	Insider	Sell	3,413	$65.00	$221,845.00	94,507
1/22/2024	Cedric Francois	CEO	Sell	13,431	$65.00	$873,015.00	320,467
1/22/2024	David O. Watson	General Counsel	Sell	4,184	$65.00	$271,960.00	105,077
1/22/2024	James George Chopas	CAO	Sell	1,061	$65.00	$68,965.00	39,067
1/22/2024	Timothy Eugene Sullivan	CFO	Sell	3,551	$65.00	$230,815.00	95,675
1/16/2024	Cedric Francois	CEO	Sell	7,851	$66.81	$524,525.31	333,898
1/16/2024	David O. Watson	General Counsel	Sell	4,240	$66.81	$283,274.40	109,261
1/16/2024	James George Chopas	CAO	Sell	864	$66.81	$57,723.84	40,128
1/16/2024	Jeffrey Eisele	Insider	Sell	438	$66.81	$29,262.78	72,650
1/16/2024	Timothy Eugene Sullivan	CFO	Sell	2,235	$66.81	$149,320.35	99,226
1/4/2024	Caroline Baumal	Insider	Sell	2,751	$60.05	$165,197.55	32,931
12/26/2023	Jeffrey Eisele	Insider	Sell	68	$57.86	$3,934.48	53,815
12/19/2023	David O. Watson	General Counsel	Sell	3,905	$57.23	$223,483.15	89,753
12/1/2023	Lukas Scheibler	Insider	Sell	10,000	$60.00	$600,000.00	68,299
11/21/2023	Cedric Francois	CEO	Sell	5,000	$48.80	$244,000.00	269,655
11/17/2023	Alec Machiels	Director	Sell	1,250	$47.74	$59,675.00	367,420
11/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$47.27	$567,240.00	1,071,807
10/23/2023	James George Chopas	CAO	Sell	132	$46.04	$6,077.28	32,680
10/23/2023	Mark Jeffrey DeLong	Insider	Sell	131	$46.04	$6,031.24	51,622
10/17/2023	Alec Machiels	Director	Sell	1,250	$48.50	$60,625.00	367,420
10/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$40.38	$484,560.00	1,066,313
9/18/2023	Alec Machiels	Director	Sell	1,250	$45.00	$56,250.00	367,420
9/18/2023	Nur Nicholson	Insider	Sell	20,350	$44.27	$900,894.50	53,284
9/15/2023	Alec Machiels	Director	Sell	1,250	$45.34	$56,675.00	367,420
9/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$42.87	$514,440.00	1,059,813
9/1/2023	Cedric Francois	CEO	Sell	150,000	$41.75	$6,262,500.00	424,655
8/31/2023	James George Chopas	CAO	Sell	551	$41.23	$22,717.73	30,312
8/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$23.66	$283,920.00	1,053,313
7/17/2023	Alec Machiels	Director	Sell	1,250	$64.79	$80,987.50	267,641
7/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$84.55	$1,014,600.00	1,046,813
7/3/2023	David O. Watson	General Counsel	Sell	8,510	$89.98	$765,729.80	85,753
7/3/2023	Timothy Eugene Sullivan	CFO	Sell	6,779	$89.97	$609,906.63	77,713
6/20/2023	Alec Machiels	Director	Sell	1,250	$88.41	$110,512.50	267,641
6/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$91.35	$1,096,200.00	1,040,313
6/5/2023	Timothy Eugene Sullivan	CFO	Sell	69,779	$88.80	$6,196,375.20	77,713
6/1/2023	Karen Lewis	Insider	Sell	5,000	$86.00	$430,000.00	41,504
5/17/2023	Alec Machiels	Director	Sell	1,250	$88.66	$110,825.00	267,641
5/16/2023	Cedric Francois	CEO	Sell	30,000	$85.66	$2,569,800.00	274,655
5/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$92.39	$1,108,680.00	1,033,813
5/3/2023	Adam J. Townsend	Insider	Sell	5,000	$82.71	$413,550.00	75,995
4/18/2023	Cedric Francois	CEO	Sell	30,000	$82.02	$2,460,600.00	637,601
4/17/2023	Alec Machiels	Director	Sell	1,250	$81.05	$101,312.50	267,641
4/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$78.21	$938,520.00	1,027,313
4/3/2023	A. Sinclair Dunlop	Director	Sell	500	$74.05	$37,025.00	131,297
4/3/2023	Karen Lewis	Insider	Sell	5,000	$75.00	$375,000.00	41,430
3/21/2023	Cedric Francois	CEO	Sell	30,000	$62.74	$1,882,200.00	1,144,591
3/17/2023	Alec Machiels	Director	Sell	1,250	$64.03	$80,037.50	267,641
3/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$63.79	$765,480.00	1,020,813
2/23/2023	Jeffrey Eisele	Insider	Sell	1,646	$68.76	$113,178.96	53,883
2/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$54.45	$653,400.00	1,006,756
2/3/2023	Adam J. Townsend	Insider	Sell	5,000	$55.85	$279,250.00	67,932
1/30/2023	Jeffrey Eisele	Insider	Sell	883	$52.76	$46,587.08	46,468
1/23/2023	Karen Lewis	Insider	Sell	2,955	$51.58	$152,418.90	37,709
1/17/2023	Alec Machiels	Director	Sell	1,250	$52.42	$65,525.00	267,641
1/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$46.08	$552,960.00	983,780
1/5/2023	Federico Grossi	Insider	Sell	2,500	$48.79	$121,975.00	94,884
1/3/2023	A. Sinclair Dunlop	Director	Sell	500	$50.70	$25,350.00	132,797
1/3/2023	Adam J. Townsend	Insider	Sell	5,000	$50.70	$253,500.00	42,907
12/19/2022	Cedric Francois	CEO	Sell	28,200	$52.06	$1,468,092.00	965,128
12/15/2022	Alec Machiels	Director	Sell	1,250	$52.35	$65,437.50	263,774
12/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.50	$570,000.00	970,280
12/5/2022	Adam J. Townsend	Insider	Sell	5,000	$50.38	$251,900.00	42,907
12/1/2022	A. Sinclair Dunlop	Director	Sell	500	$49.93	$24,965.00	129,430
12/1/2022	Federico Grossi	Insider	Sell	2,500	$49.93	$124,825.00	97,384
11/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$46.47	$557,640.00	963,780
11/3/2022	Adam J. Townsend	Insider	Sell	5,000	$58.54	$292,700.00	42,907
10/14/2022	Alec Machiels	Director	Sell	1,250	$59.31	$74,137.50	263,774
10/10/2022	Pascal Deschatelets	Insider	Sell	12,000	$57.50	$690,000.00	957,280
10/3/2022	Federico Grossi	Insider	Sell	2,500	$66.69	$166,725.00	102,384
9/15/2022	Alec Machiels	Director	Sell	1,250	$66.00	$82,500.00	263,774
9/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$63.98	$767,760.00	950,780
8/17/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$69.50	$347,500.00	29,250
8/15/2022	Adam J. Townsend	Insider	Sell	12,500	$69.00	$862,500.00	42,907
8/15/2022	Alec Machiels	Director	Sell	1,250	$67.21	$84,012.50	263,774
8/11/2022	A. Sinclair Dunlop	Director	Sell	30,000	$65.63	$1,968,900.00	255,679
8/11/2022	Adam J. Townsend	Insider	Sell	12,500	$67.00	$837,500.00	42,907
8/11/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$67.00	$335,000.00	29,250
8/3/2022	Adam J. Townsend	Insider	Sell	5,000	$56.43	$282,150.00	37,907
8/1/2022	Federico Grossi	Insider	Sell	2,500	$55.99	$139,975.00	107,384
7/27/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$57.00	$285,000.00	29,250
7/19/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$56.42	$282,100.00	29,250
7/15/2022	Alec Machiels	Director	Sell	1,250	$46.33	$57,912.50	263,774
7/11/2022	Adam J. Townsend	Insider	Sell	5,000	$48.42	$242,100.00	42,907
7/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.95	$575,400.00	937,780
6/27/2022	A. Sinclair Dunlop	Director	Sell	1,341	$46.79	$62,745.39	1,341
6/23/2022	A. Sinclair Dunlop	Director	Sell	15,000	$45.00	$675,000.00	285,679
6/22/2022	David O. Watson	General Counsel	Sell	10,000	$44.51	$445,100.00	115,569
6/17/2022	Victoria L Brown	Insider	Sell	2,698	$45.00	$121,410.00	24,974
6/16/2022	Mark Jeffrey DeLong	SVP	Sell	10,000	$41.78	$417,800.00	29,250
6/15/2022	Alec Machiels	Director	Sell	1,250	$39.29	$49,112.50	263,774
6/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$44.09	$529,080.00	891,775
6/1/2022	Federico Grossi	Insider	Sell	2,500	$41.78	$104,450.00	109,561
5/27/2022	Lukas Scheibler	Insider	Sell	10,000	$43.00	$430,000.00	40,358
5/16/2022	Alec Machiels	Director	Sell	1,250	$39.18	$48,975.00	263,774
5/2/2022	Federico Grossi	Insider	Sell	2,500	$43.56	$108,900.00	112,061
4/29/2022	Pascal Deschatelets	Insider	Sell	4,000	$44.43	$177,720.00	891,775
4/25/2022	David O. Watson	General Counsel	Sell	5,000	$50.00	$250,000.00	125,569
4/20/2022	Mark Jeffrey DeLong	SVP	Sell	7,000	$52.53	$367,710.00	28,481
4/14/2022	Alec Machiels	Director	Sell	1,250	$50.90	$63,625.00	263,774
4/4/2022	Lukas Scheibler	Insider	Sell	3,504	$56.96	$199,587.84	52,233
4/1/2022	Lukas Scheibler	Insider	Sell	11,496	$55.05	$632,854.80	52,233
3/15/2022	Alec Machiels	Director	Sell	1,250	$39.57	$49,462.50
3/15/2022	Federico Grossi	Insider	Sell	375	$39.57	$14,838.75
2/15/2022	Alec Machiels	Director	Sell	1,250	$45.43	$56,787.50
2/15/2022	Federico Grossi	Insider	Sell	375	$45.43	$17,036.25
2/11/2022	Lukas Scheibler	Insider	Sell	1,666	$46.80	$77,968.80
2/8/2022	Lukas Scheibler	Insider	Sell	10,000	$45.00	$450,000.00
1/31/2022	Lukas Scheibler	Insider	Sell	1,233	$38.47	$47,433.51

SEC Filings (Institutional Ownership Changes) for Apellis Pharmaceuticals (NASDAQ:APLS)

96.29% of Apellis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apellis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/28/2025	Entropy Technologies LP	13,960	$0.45M	0.0%	N/A	0.011%
1/27/2025	Bleakley Financial Group LLC	73,505	$2.35M	0.1%	-6.9%	0.059%
1/24/2025	Jennison Associates LLC	2,760,404	$88.08M	0.1%	+51.6%	2.219%
1/24/2025	China Universal Asset Management Co. Ltd.	26,376	$0.84M	0.1%	+12.6%	0.021%
1/23/2025	Sippican Capital Advisors	20,753	$0.66M	0.5%	-31.5%	0.017%
1/22/2025	KBC Group NV	104,287	$3.33M	0.0%	+3,862.3%	0.084%
1/15/2025	Merit Financial Group LLC	7,956	$0.25M	0.0%	N/A	0.006%
1/15/2025	Hennion & Walsh Asset Management Inc.	29,740	$0.95M	0.0%	+135.6%	0.024%
1/14/2025	Assenagon Asset Management S.A.	29,993	$0.96M	0.0%	-98.6%	0.024%
1/13/2025	Pallas Capital Advisors LLC	13,369	$0.43M	0.0%	-4.0%	0.011%
1/13/2025	Eastern Bank	21,500	$0.69M	0.0%	+87.0%	0.017%
12/26/2024	JPMorgan Chase & Co.	3,884,730	$112.04M	0.0%	+23.3%	3.123%
12/19/2024	Principal Financial Group Inc.	9,008	$0.26M	0.0%	-30.1%	0.007%
12/13/2024	Exome Asset Management LLC	100,367	$2.90M	1.9%	+114.0%	0.081%
11/27/2024	Franklin Resources Inc.	215,289	$5.90M	0.0%	-4.7%	0.173%
11/20/2024	Virtu Financial LLC	13,526	$0.39M	0.0%	N/A	0.011%
11/19/2024	Old West Investment Management LLC	102,403	$2.95M	1.1%	N/A	0.082%
11/18/2024	Toronto Dominion Bank	25,622	$0.74M	0.0%	+4.2%	0.021%
11/16/2024	Geode Capital Management LLC	1,810,526	$52.23M	0.0%	+1.3%	1.456%
11/15/2024	Barclays PLC	255,897	$7.38M	0.0%	+18.0%	0.206%
11/15/2024	Public Employees Retirement System of Ohio	37,926	$1.09M	0.0%	-4.7%	0.030%
11/15/2024	MML Investors Services LLC	13,631	$0.39M	0.0%	-10.0%	0.011%
11/15/2024	Orion Portfolio Solutions LLC	31,418	$0.91M	0.0%	-13.5%	0.025%
11/15/2024	XTX Topco Ltd	7,136	$0.21M	0.0%	N/A	0.006%
11/15/2024	Sphera Funds Management LTD.	215,873	$6.23M	1.0%	N/A	0.174%
11/15/2024	State Street Corp	4,040,861	$116.54M	0.0%	-2.6%	3.249%
11/15/2024	Stifel Financial Corp	27,641	$0.80M	0.0%	-8.8%	0.022%
11/15/2024	HighVista Strategies LLC	35,975	$1.04M	0.4%	+375.5%	0.029%
11/15/2024	Erste Asset Management GmbH	42,000	$1.24M	0.0%	N/A	0.034%
11/15/2024	True Wealth Design LLC	953	$27K	0.0%	N/A	0.001%
11/14/2024	Bellevue Group AG	19,046	$0.55M	0.0%	-95.7%	0.015%
11/14/2024	Edgestream Partners L.P.	99,401	$2.87M	0.1%	+82.1%	0.080%
11/14/2024	PDT Partners LLC	145,519	$4.20M	0.4%	+56.7%	0.117%
11/14/2024	Braidwell LP	3,125,183	$90.13M	2.6%	+410.8%	2.512%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	191,065	$5.51M	0.0%	-8.2%	0.154%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	19,212	$0.55M	0.0%	-2.0%	0.015%
11/14/2024	Fiduciary Trust Co	236,066	$6.81M	0.1%	-1.8%	0.190%
11/14/2024	FORA Capital LLC	14,623	$0.42M	0.0%	N/A	0.012%
11/13/2024	BNP Paribas Financial Markets	159,700	$4.61M	0.0%	+52.9%	0.128%
11/13/2024	FMR LLC	2,900,254	$83.64M	0.0%	-12.1%	2.332%
11/13/2024	The Manufacturers Life Insurance Company	61,221	$1.77M	0.0%	-16.3%	0.049%
11/12/2024	Algert Global LLC	82,411	$2.38M	0.1%	-33.3%	0.066%
11/12/2024	Cerity Partners LLC	31,381	$0.91M	0.0%	+311.2%	0.025%
11/12/2024	Charles Schwab Investment Management Inc.	956,362	$27.58M	0.0%	+1.0%	0.769%
11/9/2024	Landscape Capital Management L.L.C.	26,900	$0.78M	0.1%	N/A	0.022%
11/8/2024	Jennison Associates LLC	1,821,115	$52.52M	0.0%	-49.3%	1.496%
11/8/2024	PNC Financial Services Group Inc.	58,462	$1.69M	0.0%	-1.1%	0.048%
11/6/2024	KPP Advisory Services LLC	8,281	$0.24M	0.1%	-26.5%	0.007%
11/6/2024	KBC Group NV	2,632	$76K	0.0%	+34.8%	0.002%
11/5/2024	Victory Capital Management Inc.	411,906	$11.88M	0.0%	-10.8%	0.338%
11/5/2024	GSA Capital Partners LLP	28,584	$0.82M	0.1%	N/A	0.023%
11/4/2024	Lisanti Capital Growth LLC	12,505	$0.36M	0.1%	-49.7%	0.010%
11/4/2024	Wolverine Asset Management LLC	949	$27K	0.0%	N/A	0.001%
11/4/2024	State of New Jersey Common Pension Fund D	49,795	$1.44M	0.0%	+10.1%	0.041%
11/1/2024	Assetmark Inc.	46,065	$1.33M	0.0%	+6.6%	0.038%
11/1/2024	Fiera Capital Corp	1,354,469	$39.06M	0.1%	-3.3%	1.112%
11/1/2024	Capital Performance Advisors LLP	1,944	$56K	0.0%	N/A	0.002%
10/31/2024	Principal Financial Group Inc.	9,008	$0.26M	0.0%	-30.1%	0.007%
10/30/2024	Old West Investment Management LLC	102,403	$2.95M	1.1%	N/A	0.084%
10/30/2024	AlphaCentric Advisors LLC	47,500	$1.37M	1.0%	N/A	0.039%
10/28/2024	US Bancorp DE	1,896	$55K	0.0%	-34.1%	0.002%
10/28/2024	Sippican Capital Advisors	30,313	$0.87M	0.6%	+30.8%	0.025%
10/25/2024	China Universal Asset Management Co. Ltd.	23,420	$0.68M	0.1%	+64.2%	0.019%
10/25/2024	Pallas Capital Advisors LLC	13,923	$0.38M	0.0%	N/A	0.011%
10/24/2024	Wealth Enhancement Advisory Services LLC	13,953	$0.40M	0.0%	N/A	0.011%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	4,404	$0.13M	0.0%	+21.6%	0.004%
10/23/2024	Assenagon Asset Management S.A.	2,144,415	$61.85M	0.1%	+191.9%	1.767%
10/23/2024	Hennion & Walsh Asset Management Inc.	12,625	$0.36M	0.0%	-9.5%	0.010%
10/22/2024	Eastern Bank	11,500	$0.33M	0.0%	N/A	0.009%
10/19/2024	Allspring Global Investments Holdings LLC	6,522	$0.19M	0.0%	-91.0%	0.005%
10/8/2024	CWM LLC	23,722	$0.68M	0.0%	+471.5%	0.020%
10/5/2024	Handelsbanken Fonder AB	27,600	$0.80M	0.0%	+15.5%	0.023%
10/3/2024	Duncan Williams Asset Management LLC	21,125	$0.61M	0.3%	N/A	0.017%
8/26/2024	Teachers Retirement System of The State of Kentucky	18,912	$0.73M	0.0%	N/A	0.016%
8/16/2024	Algert Global LLC	123,628	$4.74M	0.2%	+137.8%	0.102%
8/15/2024	Mackenzie Financial Corp	7,939	$0.31M	0.0%	-74.4%	0.007%
8/15/2024	The Manufacturers Life Insurance Company	73,135	$2.81M	0.0%	-40.7%	0.060%
8/15/2024	AQR Capital Management LLC	246,880	$9.18M	0.0%	+337.3%	0.203%
8/15/2024	Toronto Dominion Bank	24,600	$0.94M	0.0%	+146.0%	0.020%
8/14/2024	Squarepoint Ops LLC	61,258	$2.35M	0.0%	N/A	0.050%
8/14/2024	Xponance Inc.	13,773	$0.53M	0.0%	+7.6%	0.011%
8/14/2024	Bank of Montreal Can	132,318	$5.36M	0.0%	-0.5%	0.109%
8/14/2024	HighVista Strategies LLC	7,566	$0.29M	0.1%	+4.1%	0.006%
8/14/2024	ProShare Advisors LLC	7,492	$0.29M	0.0%	-11.4%	0.006%
8/14/2024	Profund Advisors LLC	42,968	$1.65M	0.1%	+90.7%	0.035%
8/13/2024	Ensign Peak Advisors Inc	82,997	$3.18M	0.0%	-68.1%	0.068%
8/13/2024	Sei Investments Co.	34,666	$1.33M	0.0%	-13.0%	0.029%
8/12/2024	Seven Eight Capital LP	7,101	$0.27M	0.0%	-61.5%	0.006%
8/12/2024	Hsbc Holdings PLC	34,924	$1.34M	0.0%	-64.6%	0.029%
8/12/2024	Amalgamated Bank	6,995	$0.27M	0.0%	+5.4%	0.006%
8/12/2024	E Fund Management Co. Ltd.	14,696	$0.56M	0.0%	+109.0%	0.012%
8/10/2024	Mutual of America Capital Management LLC	27,466	$1.05M	0.0%	-4.1%	0.023%
8/9/2024	Edgestream Partners L.P.	54,572	$2.09M	0.1%	+240.4%	0.045%
8/9/2024	Dimensional Fund Advisors LP	33,696	$1.29M	0.0%	-50.6%	0.028%
8/8/2024	Envestnet Asset Management Inc.	134,536	$5.16M	0.0%	+42.2%	0.111%
8/8/2024	Oppenheimer Asset Management Inc.	12,754	$0.49M	0.0%	+46.7%	0.011%
8/8/2024	State of New Jersey Common Pension Fund D	45,241	$1.74M	0.0%	+6.6%	0.037%
8/6/2024	Savant Capital LLC	13,598	$0.52M	0.0%	N/A	0.011%
8/6/2024	Candriam S.C.A.	543,035	$20.83M	0.1%	-7.2%	0.447%
8/5/2024	Arizona State Retirement System	22,013	$0.84M	0.0%	+12.7%	0.018%

Data available starting January 2016

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops APL-3007, a small interfering RNA, or siRNA, which is in a Phase 1 clinical trial, as well as an oral complement inhibitor that is in preclinical development. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

Today's Range

Now: $29.28

$28.72

$30.11

50 Day Range

MA: $32.16

$27.44

$35.42

52 Week Range

Now: $29.28

$24.34

$71.90

Volume

2,589,526 shs

Average Volume

2,102,290 shs

Market Capitalization

$3.64 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top insider investors include:
Cedric Francois (CEO)
Pascal Deschatelets (Insider)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Timothy Eugene Sullivan (CFO)
Adam J Townsend (Insider)
Nur Nicholson (Insider)
Jeffrey Eisele (Insider)
Lukas Scheibler (Insider)
Caroline Baumal (Insider)
Mark Jeffrey Delong (Insider)
James George Chopas (CAO)
Karen Lewis (Insider)
Learn More about top insider investors at Apellis Pharmaceuticals.
Who are the major institutional investors of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top institutional shareholders include:
Jennison Associates LLC — 2.22%
KBC Group NV — 0.08%
Bleakley Financial Group LLC — 0.06%
SG Americas Securities LLC — 0.00%
Assenagon Asset Management S.A. — 0.02%
Hennion & Walsh Asset Management Inc. — 0.02%
Learn More about top institutional investors of Apellis Pharmaceuticals stock.
Which institutional investors are selling Apellis Pharmaceuticals stock?: Within the last quarter, APLS stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Sippican Capital Advisors
Bleakley Financial Group LLC
Pallas Capital Advisors LLC
In the last year, company insiders that have sold Apellis Pharmaceuticals company stock include:
Cedric Francois (CEO)
Pascal Deschatelets (Insider)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Timothy Eugene Sullivan (CFO)
Adam J Townsend (Insider)
Nur Nicholson (Insider)
Jeffrey Eisele (Insider)
Lukas Scheibler (Insider)
Caroline Baumal (Insider)
Learn More investors selling Apellis Pharmaceuticals stock.
Which institutional investors are buying Apellis Pharmaceuticals stock?: During the previous quarter, APLS stock was purchased by institutional investors including:
Jennison Associates LLC
KBC Group NV
Hennion & Walsh Asset Management Inc.
Entropy Technologies LP
Eastern Bank
Merit Financial Group LLC
China Universal Asset Management Co. Ltd.